Cell Banking
Comprehensive Cell Banking Solutions
Eurofins CDMO, a leading Contract Development & Manufacturing Organization (CDMO), takes pride in its extensive capabilities for the development, manufacturing, and characterization of a diverse range of cell banks. Our network of companies offers expert cell banking services for microbial (bacteria/yeast), mammalian, insect cell banks, and even virus seeds. We provide a complete portfolio of cell banking solutions, including the production of Master Cell Banks (MCB) and Working Cell Banks (WCB) or End-of-Production Cell Banks (EoPC) in BSL2 cleanrooms. All activities, including QC release and stability testing, strictly adhere to the rigorous requirements set forth by the EMA and/or FDA. For your research needs, we can also deliver Research Cell Banks with QC testing analogous to the GMP standard. Additionally, Eurofins CDMO boasts extensive expertise in developing and conducting Cell-based Assays to support both preclinical and clinical studies. With our unwavering commitment to quality and compliance, we empower (bio)pharmaceutical companies to move rapidly from research to clinical stages, accelerating time-to-market for life-changing therapies.
Compliance and Quality Assured
At Eurofins CDMO, we recognize the critical importance of adhering to stringent regulatory standards in the pharmaceutical industry. Our team of experts ensures that every aspect of our cell banking services aligns with the highest quality and compliance benchmarks set by the EMA and FDA. Whether it's the production of Master Cell Banks or Working Cell Banks, we conduct all activities within BSL2 cleanrooms, safeguarding the integrity and stability of the cell lines. Our QC release and stability testing procedures undergo thorough scrutiny, ensuring that the generated cell banks meet the necessary regulatory requirements for clinical development. By entrusting Eurofins CDMO with your cell banking needs, you can rest assured that your projects are in the hands of dedicated professionals committed to delivering excellence at every stage of drug development.
Partnering for Success
Eurofins CDMO stands as a reliable partner, supporting (bio)pharmaceutical companies in their journey to bring groundbreaking therapies to patients worldwide. Our expertise in cell banking services empowers clients to unlock their drug development potential and accelerate time-to-market. Whether you require expertly manufactured Master Cell Banks (MCB), Working Cell Banks (WCB), or End-of-Production Cell Banks (EoPC), we have the capabilities and infrastructure to cater to diverse project needs. Our proficiency in Cell-based Assays further complements our comprehensive solutions, aiding preclinical and clinical studies with robust analytical support. As you embark on the path of innovation, Eurofins CDMO is here to guide you with unmatched expertise, ensuring compliance, quality, and efficiency throughout your drug development journey. Don't miss the opportunity to unleash the full potential of your pharmaceutical projects.
